It has been suggested in recent research that interleukin-1 (IL-1) and
interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's d
isease (AD). Production of IL-1, by lipopolysaccharide (LPS)-stimulate
d monocytes, and IL-6, by phytohaemagglutinin (PHA)-stimulated mononuc
lear cells, was assessed in patients with AD divided into two groups -
mild and moderately severe - according to severity of disease, and el
derly controls. No differences in IL-1 production were found among AD
patients and controls. However, significant elevation in IL-6 secretio
n levels was observed in both the mild and moderately severe AD patien
ts. Our results suggest that peripheral IL-6 secretion levels may be r
esponsible for acute-phase proteins observed in the serum of AD patien
ts.